HEPION PHARMS INC HEPA

$0.07 +7.14% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-08-13 View →
4 4 2026-08-12 View →
4 4 2026-08-12 View →
4 4 2026-08-12 View →
4 4 2026-08-12 View →
4 4 2026-08-12 View →
8-K 8-K 2026-08-04 View →
8-K 8-K 2026-07-02 View →
8-K 8-K 2026-06-17 View →
10-Q 10-Q 2026-05-14 View →
DEF 14A DEF 14A 2026-04-28 View →
4 4 2026-04-27 View →
4 4 2026-04-27 View →
4 4 2026-04-27 View →
4 4 2026-04-27 View →
8-K 8-K 2026-04-22 View →
8-K 8-K 2026-04-14 View →
8-K 8-K 2026-03-18 View →
10-K 10-K 2026-03-12 View →
8-K 8-K 2026-03-03 View →
8-K 8-K 2026-01-15 View →
10-Q 10-Q 2025-11-12 View →
10-Q 10-Q 2025-08-14 View →
8-K 8-K 2025-06-30 View →
8-K 8-K 2025-06-12 View →
8-K 8-K 2025-06-09 View →
8-K 8-K 2025-05-30 View →
10-Q 10-Q 2025-05-19 View →
8-K 8-K 2025-05-12 View →
8-K 8-K 2025-05-06 View →
DEF 14A Proxy statement 2025-04-28 View →
8-K Current report (material event) 2025-04-17 View →
10-K Annual report 2025-04-08 View →
8-K Current report (material event) 2025-03-20 View →
8-K Current report (material event) 2025-03-19 View →
8-K Current report (material event) 2025-03-10 View →
8-K Current report (material event) 2025-03-04 View →
DEF 14A Proxy statement 2025-02-07 View →
8-K Current report (material event) 2025-01-15 View →
S-1 IPO registration 2024-12-26 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$0.07
Market Cap
52-Week Range
$0.03 $0.25
Average Volume
40K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.